Raising investment limit of LIC is imprudent: Irda Chief

Tags: IRDA, LIC, Insurance
Irda chairman J Hari Narayan today said the government's recent move to allow the

RELATED ARTICLES

state-owned insurer, LIC, to invest up to 30 per cent in a company was imprudent.

He also said it is a matter of legal interpretation.

"I think, it is imprudent," Narayan told reporters on the sidelines of an Insurance Brokers Association of India event.

"Our interpretation was that LIC should be treated at par with all other private insurers. But the government was of the view that there were certain provisions, only applicable to LIC (as per LIC Act). So, it's a question of legal position," Hari Narayan said.

The government has allowed LIC to invest up to 30 per cent in a company against the existing norm of 10 per cent as stipulated in the Insurance Act, 1999 after the Law Ministry clarified that LIC Act, 1959 supersedes the Insurance Act, 1999.

The government is likely to notify the new rules soon.

Referring to the autonomy of regulators, Insurance Regulatory Development Authority (IRDA) Chief said the regulator has enough autonomy and the present issue of difference in approach to LIC case was a matter of legal position.

Meanwhile, he said the board of the Insurance Advisory Council would meet shortly to discuss the new product design guidelines.

"The product design guidelines have been examined by the council. They now have to be approved by the board and they are meeting on January 9," Narayan said without divulging any details regarding the proposed guidelines.

He also said management expenses of the insurance industry in the country were one of the highest in the world and needed a relook.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

FC NEWSLETTER

Stay informed on our latest news!

EDITORIAL OF THE DAY

  • Daiichi’s legal move against Ranbaxy’s ex-promoters will set precedence

    Daiichi Sankyo’s decision to take the former promoters of Ranbaxy to court is welcome move.

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Roopen Roy

Where is the Charging Bull headed to?

On a balmy spring morning last week, I was admiring ...

Rajgopal Nidamboor

The disdainful wrath of greed

It is rightly said that money isn’t the root of ...

Gautam Gupta

Immense potential of e-commerce in fashion and apparel

Michael Aldrich launched online shopping in1979 with no clue whatsoever ...